Pathstone Family Office, LLC Uro Gen Pharma Ltd. Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$23.83 - $36.44 $975,838 - $1.49 Million
-40,950 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$32.75 - $40.35 $1.34 Million - $1.65 Million
40,950 New
40,950 $1.47 Million
Q1 2019

May 14, 2019
SELL
$35.47 - $54.55 $1.37 Million - $2.11 Million
-38,700 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$38.35 - $50.39 $1.48 Million - $1.95 Million
38,700 New
38,700 $1.67 Million

Others Institutions Holding URGN

# of Institutions
142
Shares Held
41.6M
Call Options Held
91.4K
Put Options Held
42.1K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $189M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email